Dimiracetam

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameDimiracetam
Drug Alias Name地来西坦dimiracetamdimiracetamumBND-11624ISF-4185 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNervous System DiseasesAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaSwitzerland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurotune Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurotune Ag
Active IndicationsN/A
Inactive IndicationsNervous System DiseasesAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksWikipedia